CONNIE HUHN: Open Payments
NPI 1780186254 · IONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 17 payments from 11 companies in 2025. Trend: 2023 $236 · 2024 $507 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Corium, LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Azstarys, JARDIANCE, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
